# RedactBio, Inc. — Form D

RedactBio, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-07. The offering totals $2.0M, of which $500K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-05-07
- Form: D
- Accession: 0001775432-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $500K
- Remaining: $1.5M
- Investors: 1
- Date of first sale: 2019-04-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-338988

## Issuer

- Name: RedactBio, Inc.
- CIK: 0001775432
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 405 WALTHAM STREET, LEXINGTON, MA, 02421-7934
- Phone: 617-531-0700

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Christopher V Gemmiti | Director | Lexington, MA |
| Geoff V MacKay | Director | Lexington, MA |
| Christopher V Gemmiti | Executive Officer | Lexington, MA |
| Geoff V MacKay | Executive Officer | Lexington, MA |

## More

- [CIK 1775432 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1775432&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001775432-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.